ArticleEuropean journal of radiology open2018
Characterization of diffuse orbital mass using Apparent diffusion coefficient in 3-tesla MRI.
Article in European journal of radiology open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Differentiation between benign and malignant orbital tumors using deep transfer learning features and hand-crafted radiomics features from traditional CT imaging.Frontiers in oncology · 2026Article
- Assessing MRI interpretability of the orbit, paranasal sinuses, and nasopharynx in cochlear implant patients.Frontiers in neurology · 2025Article
- Diagnostic Performance of Dynamic Contrast-Enhanced 3T MR Imaging for Characterization of Orbital Lesions: Validation in a Large Prospective Study.AJNR. American journal of neuroradiology · 2024Article
- A signature of structural MRI features at 3 Tesla allows an accurate characterization of orbital cavernous venous malformation.European radiology · 2023Article
- Advances in magnetic resonance imaging of orbital disease.Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2022Article
- Lacrimal Gland Lesions Biopsied in a Tertiary Eye Center in Saudi Arabia: A Clinical, Radiological, Surgical, and Histological Review.Clinical ophthalmology (Auckland, N.Z.) · 2022Article
- Morphologic Cross-Sectional Imaging Features of IgG4-Related Orbitopathy in Comparison to Ocular Adnexal Lymphoma.Clinical ophthalmology (Auckland, N.Z.) · 2021Article
- To Explore MR Imaging Radiomics for the Differentiation of Orbital Lymphoma and IgG4-Related Ophthalmic Disease.BioMed research international · 2021Article
- Intravoxel incoherent motion (IVIM) 3 T MRI for orbital lesion characterization.European radiology · 2021Article
- Quantitative characterization of extraocular orbital lesions in children using diffusion-weighted imaging.Pediatric radiology · 2021Article
- MRI of Pediatric Orbital Masses: Role of Quantitative Diffusion-weighted Imaging in Differentiating Benign from Malignant Lesions.Clinical neuroradiology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate if the apparent diffusion coefficient (ADC) value in diffusion-weighted magnetic resonance imaging (DW-MRI) improves the diagnostic accuracy of diffuse orbital masses. MATERIALS AND
methodsADC DW-MRI was used to evaluate cases of diffuse orbital masses at our institution from 2000 to 2015. Lesions were grouped according to histopathologic diagnosis as, benign, pre-malignant and malignant. Lymphoproliferative lesions were further subgrouped as lymphoma or other lymphoproliferative lesions. The validity of the ADC value for the diffuse orbital mass was compared between groups. The area under curve (AUC) was also calculated.
resultsThirty-nine cases of diffuse orbital masses were evaluated. The median ADC was 0.58 (25% quartile 0.48; minimum: 0.45; maximum: 1.72 × 10
conclusionADC is a promising imaging metric to characterize malignant and benign diffuse orbital masses and to distinguish lymphomas from other non-lymphoproliferative lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.